TY - JOUR AU - Mattiuzzi, C. AU - Lippi, G. PY - 2019 DA - 2019// TI - Current cancer epidemiology JO - J Epidemiol Global Health VL - 9 ID - Mattiuzzi2019 ER - TY - JOUR AU - Goerling, U. AU - Stickel, A. PY - 2014 DA - 2014// TI - Quality of life in oncology JO - Recent Results Cancer Res VL - 197 ID - Goerling2014 ER - TY - JOUR AU - Jitender, S. AU - Mahajan, R. AU - Rathore, V. AU - Choudhary, R. PY - 2018 DA - 2018// TI - Quality of life of cancer patients JO - J Exp Ther Oncol VL - 12 ID - Jitender2018 ER - TY - BOOK AU - Bussing, A. PY - 2000 DA - 2000// TI - Mistletoe: the genus Viscum PB - Harwood Academic CY - Amsterdam ID - Bussing2000 ER - TY - BOOK AU - Pfüller, U. PY - 2003 DA - 2003// TI - Chemical Constituents of European Mistletoe (Viscum album L.) Isolation and Characterisation of the Main Relevant Ingredients: Lectins, Viscotoxins, Oligo−/polysaccharides, Flavonoides, Alkaloids PB - CRC Press CY - Mistletoe ID - Pfüller2003 ER - TY - STD TI - Berg JM, Tymoczko JL, Stryer L. Biochemistry. Jeremy M. Berg, John L. Tymoczko, Lubert Stryer; with Gregory J. Gatto, Jr. New York: WH Freeman; 2012. ID - ref6 ER - TY - JOUR AU - Hoessli, D. C. AU - Ahmad, I. PY - 2008 DA - 2008// TI - Mistletoe lectins: carbohydrate-specific apoptosis inducers and immunomodulators JO - Curr Org Chem VL - 12 ID - Hoessli2008 ER - TY - JOUR AU - Hajto, T. AU - Hostanska, K. AU - Gabius, H. -. J. PY - 1989 DA - 1989// TI - Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients JO - Cancer Res VL - 49 ID - Hajto1989 ER - TY - JOUR AU - Hülsen, H. AU - Born, U. PY - 1993 DA - 1993// TI - Einfluss von Mistelpräparaten auf die in-vitro-Aktivität der natürlichen Killerzellen von Krebspatienten (Teil 2) JO - Therapeutikon. VL - 7 ID - Hülsen1993 ER - TY - JOUR AU - Büssing, A. AU - Suzart, K. AU - Bergmann, J. AU - Pfüller, U. AU - Schietzel, M. AU - Schweizer, K. PY - 1996 DA - 1996// TI - Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins JO - Cancer Lett VL - 99 ID - Büssing1996 ER - TY - JOUR AU - Greń, A. AU - Formicki, G. AU - Massanyi, P. AU - Szaroma, W. AU - Lukáč, N. AU - Kapusta, E. PY - 2019 DA - 2019// TI - Use of Iscador, an extract of mistletoe (Viscum album L.) in treatment. Journal of microbiology JO - Biotechnol Food Sci VL - 2019 ID - Greń2019 ER - TY - JOUR AU - Huber, R. AU - Rostock, M. AU - Goedl, R. AU - Ludtke, R. AU - Urech, K. AU - Buck, S. PY - 2005 DA - 2005// TI - Mistletoe treatment induces GM-CSF-and IL-5 production by PBMC and increases blood granulocyte-and eosinophil counts: a placebo controlled randomized study in healthy subjects JO - Eur J Med Res VL - 10 ID - Huber2005 ER - TY - STD TI - Oei SL, Thronicke A, Schad F. Mistletoe and immunomodulation: insights and implications for anticancer therapies. Evid Based Complement Alternat Med. 2019;2019:5893017. https://doi.org/10.1155/2019/5893017. ID - ref13 ER - TY - STD TI - Büssing A, Raak C, Ostermann T. Quality of life and related dimensions in cancer patients treated with mistletoe extract (iscador): a meta-analysis. Evid Based Complement Alternat Med. 2012;2012. ID - ref14 ER - TY - JOUR AU - Ernst, E. AU - Schmidt, K. AU - Steuer-Vogt, M. K. PY - 2003 DA - 2003// TI - Mistletoe for cancer? A systematic review of randomised clinical trials JO - Int J Cancer VL - 107 ID - Ernst2003 ER - TY - STD TI - Freuding M, Keinki C, Kutschan S, Micke O, Buentzel J, Huebner J. Mistletoe in oncological treatment: a systematic review: part 2: quality of life and toxicity of cancer treatment. J Cancer Res Clin Oncol. 2019b. ID - ref16 ER - TY - JOUR AU - Freuding, M. AU - Keinki, C. AU - Micke, O. AU - Buentzel, J. AU - Huebner, J. PY - 2019 DA - 2019// TI - Mistletoe in oncological treatment: a systematic review JO - J Cancer Res Clin Oncol VL - 145 ID - Freuding2019 ER - TY - STD TI - Horneber M, Bueschel G, Huber R, Linde K, Rostock M. Mistletoe therapy in oncology. Cochrane Database Syst Rev. 2008;(2). ID - ref18 ER - TY - JOUR AU - Kienle, G. S. AU - Kiene, H. PY - 2010 DA - 2010// TI - Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies JO - Integr Cancer Ther VL - 9 ID - Kienle2010 ER - TY - JOUR AU - Melzer, J. AU - Iten, F. AU - Hostanska, K. AU - Saller, R. PY - 2009 DA - 2009// TI - Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases JO - Complement Med Res VL - 16 ID - Melzer2009 ER - TY - BOOK PY - 2019 DA - 2019// TI - Cochrane Handbook for Systematic Reviews of Interventions Version 6: The Cochrane Collaboration ID - ref21 ER - TY - STD TI - Cochrane. RoB 2: A revised Cochrane risk-of-bias tool for randomized trials 2019 [Available from: https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. UR - https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials ID - ref22 ER - TY - STD TI - Wells G. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses. 2001. http://www.ohri.ca/programs/clinical_epidemiology/oxfordasp. Accessed 11 Aug 2019. UR - http://www.ohri.ca/programs/clinical_epidemiology/oxfordasp ID - ref23 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. PY - 2002 DA - 2002// TI - Quantifying heterogeneity in a meta-analysis JO - Stat Med VL - 21 ID - Higgins2002 ER - TY - BOOK AU - Sterne, J. A. AU - Egger, M. PY - 2005 DA - 2005// TI - Regression methods to detect publication and other bias in meta-analysis. Publication bias in meta-analysis: Prevention, assessment and adjustments ID - Sterne2005 ER - TY - JOUR AU - Bar-Sela, G. AU - Wollner, M. AU - Hammer, L. AU - Agbarya, A. AU - Dudnik, E. AU - Haim, N. PY - 2013 DA - 2013// TI - Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study JO - Eur J Cancer VL - 49 ID - Bar-Sela2013 ER - TY - JOUR AU - Borrelli, E. PY - 2001 DA - 2001// TI - Evaluation of the quality of life in breast cancer patients undergoing lectin standardized mistletoe therapy JO - Minerva Medica VL - 92 ID - Borrelli2001 ER - TY - BOOK AU - Dold, U. AU - LE AU - Mäurer, H. C. AU - Müller-Wening, D. AU - Sakellariou, B. AU - Trendelenburg, F. AU - Wagner, G. PY - 1991 DA - 1991// TI - Krebszusatztherapie beim fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom PB - Georg Thieme Verlag CY - Stuttgart-New York ID - Dold1991 ER - TY - JOUR AU - Enesel, M. B. AU - Acalovschi, I. AU - Grosu, V. AU - Sbarcea, A. AU - Rusu, C. AU - Dobre, A. PY - 2005 DA - 2005// TI - Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients JO - Anticancer Res VL - 25 ID - Enesel2005 ER - TY - BOOK AU - Grah, C. PY - 2010 DA - 2010// TI - Misteltherapie bei nichtkleinzelligem Bronchialkarzinom PB - Fu-Berlin CY - Berlin ID - Grah2010 ER - TY - JOUR AU - Grossarth-Maticek, R. AU - Ziegler, R. PY - 2006 DA - 2006// TI - Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador®) JO - Complement Med Res VL - 13 ID - Grossarth-Maticek2006 ER - TY - JOUR AU - Grossarth-Maticek, R. AU - Ziegler, R. PY - 2006 DA - 2006// TI - Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis JO - Eur J Med Res VL - 11 ID - Grossarth-Maticek2006 ER - TY - STD TI - Grossarth-Maticek R, Ziegler R. Efficacy and safety of the long-term treatment of melanoma with a mistletoe preparation (Iscador). Schweizerische Zeitschrift für Ganzheitsmedizin. 2007c;19(6):325. ID - ref33 ER - TY - JOUR AU - Grossarth-Maticek, R. AU - Ziegler, R. PY - 2007 DA - 2007// TI - Prospective controlled cohort studies on long-term therapy of ovarian cancer patients with mistletoe (Viscum album L.) extracts Iscador JO - Arzneimittelforschung. VL - 57 ID - Grossarth-Maticek2007 ER - TY - JOUR AU - Grossarth-Maticek, R. AU - Ziegler, R. PY - 2007 DA - 2007// TI - Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador®) JO - Complement Med Res VL - 14 ID - Grossarth-Maticek2007 ER - TY - JOUR AU - Grossarth-Maticek, R. AU - Ziegler, R. PY - 2008 DA - 2008// TI - Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador) JO - Eur J Med Res VL - 13 ID - Grossarth-Maticek2008 ER - TY - JOUR AU - Heiny, B. PY - 1991 DA - 1991// TI - Additive Therapie mit standardisiertem Mistelextrakt reduziert die Leukopenie und verbessert die Lebensqualität von Patientinnen mit fortgeschrittenem Mammakarzinom unter palliativer Chemotherapie (VEC-schema) JO - Krebsmedizin. VL - 12 ID - Heiny1991 ER - TY - JOUR AU - Heiny, B. M. AU - Albrecht, V. AU - Beuth, J. PY - 1998 DA - 1998// TI - Stabilization of the quality of life by mistletoe lectin-1 standardized mistletoe extract in advanced colorectal carcinoma JO - Onkologe. VL - 4 ID - Heiny1998 ER - TY - STD TI - Kaiser G, Büschel M, Horneber M, Smetak M, Birkmann J, Braun W, et al. Studiendesign und erste Ergebnisse einer prospektiven placebokontrollierten, randomisierten Studie mit AbnobaViscum Mali 4. [Prospective, randomised, placebo-controlled, double-blind study with a mistletoe extract: Study design and early results]. In: Scheer R, Bauer R, Becker H, Berg PA, Fintelmann V, editors. Die Mistel in der Tumortherapie: Grundlagenforschung und Klinik [Mistletoe in tumor therapy: Basic research and clinic]. Essen: KVC publisher; 2001. p. 485–505. . ID - ref39 ER - TY - JOUR AU - Kim, K. C. AU - Yook, J. H. AU - Eisenbraun, J. AU - Kim, B. S. AU - Huber, R. PY - 2012 DA - 2012// TI - Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study JO - BMC Complement Altern Med VL - 12 ID - Kim2012 ER - TY - JOUR AU - Lenartz, D. AU - Stoffel, B. AU - Menzel, J. AU - Beuth, J. PY - 1996 DA - 1996// TI - Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients JO - Anticancer Res VL - 16 ID - Lenartz1996 ER - TY - JOUR AU - Loewe-Mesch, A. AU - Kuehn, J. AU - Borho, K. AU - Abel, U. AU - Bauer, C. AU - Gerhard, I. PY - 2008 DA - 2008// TI - Adjuvante simultane Mistel−/Chemotherapie bei Mammakarzinom–Einfluss auf Immunparameter, Lebensqualität und Verträglichkeit JO - Complement Med Res VL - 15 ID - Loewe-Mesch2008 ER - TY - JOUR AU - Longhi, A. AU - Mariani, E. AU - Kuehn, J. J. PY - 2009 DA - 2009// TI - A randomized study with adjuvant mistletoe versus oral Etoposide on post relapse disease-free survival in osteosarcoma patients JO - Eur J Integr Med VL - 1 ID - Longhi2009 ER - TY - JOUR AU - Piao, B. K. AU - Wang, Y. X. AU - Xie, G. R. AU - Mansmann, U. AU - Matthes, H. AU - Beuth, J. PY - 2004 DA - 2004// TI - Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial JO - Anticancer Res VL - 24 ID - Piao2004 ER - TY - JOUR AU - Semiglasov, V. F. AU - Stepula, V. V. AU - Dudov, A. AU - Lehmacher, W. AU - Mengs, U. PY - 2004 DA - 2004// TI - The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial JO - Anticancer Res VL - 24 ID - Semiglasov2004 ER - TY - JOUR AU - Semiglazov, V. F. AU - Stepula, V. V. AU - Dudov, A. AU - Schnitker, J. AU - Mengs, U. PY - 2006 DA - 2006// TI - Quality of life is improved in breast cancer patients by standardised mistletoe extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial JO - Anticancer Res VL - 26 ID - Semiglazov2006 ER - TY - JOUR AU - Steuer-Vogt, M. AU - Bonkowsky, V. AU - Scholz, M. AU - Fauser, C. AU - Licht, K. AU - Ambrosch, P. PY - 2006 DA - 2006// TI - Influence of ML-1 standardized mistletoe extract on the quality of life in head and neck cancer patients JO - Hno. VL - 54 ID - Steuer-Vogt2006 ER - TY - STD TI - Tröger W, Jezdic S, Zdrale Z, Tisma N, Hamre HJ, Matijasevic M. Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone. Breast Cancer. 2009;3(1):35–45. ID - ref48 ER - TY - STD TI - Tröger W, Zdrale Z, Tisma N, Matijasevic M. Additional therapy with a mistletoe product during adjuvant chemotherapy of breast cancer patients improves quality of life: an open randomized clinical pilot trial. Evid Based Complement Alternat Med. 2014a;2014: 430518. https://doi.org/10.1155/2014/430518. ID - ref49 ER - TY - JOUR AU - Tröger, W. AU - Galun, D. AU - Reif, M. AU - Schumann, A. AU - Stanković, N. AU - Milićević, M. PY - 2014 DA - 2014// TI - Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial JO - Deutsches Ärzteblatt International VL - 111 ID - Tröger2014 ER - TY - JOUR AU - Tröger, W. AU - Galun, D. AU - Reif, M. AU - Schumann, A. AU - Stankovic, N. AU - Milicevic, M. PY - 2014 DA - 2014// TI - Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial JO - Dtsch Arztebl Int VL - 111 ID - Tröger2014 ER - TY - STD TI - Longhi A, Reif M, Mariani E, Ferrari S. A randomized study on postrelapse disease-free survival with adjuvant mistletoe versus oral etoposide in osteosarcoma patients. Evid Based Complement Alternat Med. 2014;2014:210198. https://doi.org/10.1155/2014/210198. ID - ref52 ER - TY - JOUR AU - Rohr, E. AU - Pampallona, S. AU - Wegberg, B. AU - Cerny, T. AU - Hürny, C. AU - Bernhard, J. PY - 2000 DA - 2000// TI - Attitudes and beliefs towards disease and treatment in patients with advanced cancer using anthroposophical medicine JO - Oncol Res Treat VL - 23 ID - Rohr2000 ER - TY - JOUR AU - Beadle, G. F. AU - Yates, P. AU - Najman, J. M. AU - Clavarino, A. AU - Thomson, D. AU - Williams, G. PY - 2004 DA - 2004// TI - Illusions in advanced cancer: the effect of belief systems and attitudes on quality of life JO - Psycho-Oncol VL - 13 ID - Beadle2004 ER - TY - BOOK AU - Cohen, J. PY - 1988 DA - 1988// TI - Statistical power analysis for the behavioral sciences PB - Lawrence Erlbaum Associates, Publishers CY - Hillsdale, NJ ID - Cohen1988 ER - TY - JOUR AU - Osoba, D. AU - Rodrigues, G. AU - Myles, J. AU - Zee, B. AU - Pater, J. PY - 1998 DA - 1998// TI - Interpreting the significance of changes in health-related quality-of-life scores JO - J Clin Oncol VL - 16 ID - Osoba1998 ER - TY - JOUR AU - Cella, D. AU - Eton, D. T. AU - Fairclough, D. L. AU - Bonomi, P. AU - Heyes, A. E. AU - Silberman, C. PY - 2002 DA - 2002// TI - What is a clinically meaningful change on the functional assessment of Cancer therapy–lung (FACT-L) questionnaire?: results from eastern cooperative oncology group (ECOG) study 5592 JO - J Clin Epidemiol VL - 55 ID - Cella2002 ER -